Neuroendocrine considerations in the treatment of men and women with epilepsy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23237902.
- Also identified by DOI 10.1016/S1474-4422(12)70239-9 and PMC identifier 4928713.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Complex, multidirectional interactions between hormones, seizures, and the medications used to control them can present a challenge for clinicians treating patients with epilepsy. Many hormones act as neurosteroids, modulating brain excitability via direct binding sites. Thus, changes in endogenous or exogenous hormone levels can affect the occurrence of seizures directly as well as indirectly through pharmacokinetic effects that alter the concentrations of antiepileptic drugs. The underlying structural and physiological brain abnormalities of epilepsy and the metabolic activity of antiepileptic drugs can adversely affect hypothalamic and gonadal functioning. Knowledge of these complex interactions has increased and can now be incorporated in meaningful treatment approaches for men and women with epilepsy.
Medical subject headings
- Anticonvulsants
- Brain
- Epilepsy
- Neurotransmitter Agents